Alzheimer's disease: Modeling current and potential targets
By the time we are 65, one in ten of us will have Alzheimer’s disease. There are only four FDA approved drugs for the alleviation of the symptoms but none that actually treat the disease. Andy Smith explains how computational chemistry is a valuable resource in helping to characterize and understand new protein targets.
2 - 3, 2nd RSC-BMCS / RSC-CICAG Artificial Intelligence in Chemistry, UK
1 - 5 EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Greece - Meet us at stand 1 for an overview of Torx™, a next generation platform for small molecule discovery focused on team working and collaboration 4 - 6, 7th Annual CCPBioSim Conference - Frontiers in Biomolecular Simulation, UK 8 - 11, 20th SCI/RSC Medicinal Chemistry Symposium, UK - Meet us at stand D for a demonstration of Torx™, a next generation platform for small molecule discovery focused on team working and collaboration 11, Redefining Early Stage Investments (RESI), UK 25, Chemistry Networks: Focus on AI and Machine Learning, UK 25 - 27, 8th RDKit User Group Meeting, Germany 25 - 26, 19th Annual Biotech in Europe Forum, Switzerland 26, UK QSAR Autumn Meeting, UK
Bionow is an award-winning specialist business development and services
company serving the life science sector in the North of England. We welcome enquiries and
the opportunity to speak with current or potential members. If you would like to find out
more about membership to Bionow, our highly knowledgeable team, and the support we can
Bionow supports business growth, competitiveness and innovation within the biomedical and
life science sectors across Northern England. We add significant value to our members
through a range of specialist services, expert guidance and knowledge sharing, and focused
networking events. Our service is proven, confidential and we would welcome the opportunity
to accept you into our membership!